Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

At the five-year celebration event, scientists and health study volunteers from across the DPUK partnership came together to launch one of the world’s most in-depth study's into preclinical Alzheimer’s disease - one of the most important outcomes from DPUK's work to transform dementia research infrastructure in the UK.

The event saw scientists from each of the major research networks in Dementias Platform UK (DPUK) – Imaging, Stem Cells and Informatics – come together with many of the lead researchers of large clinical studies into dementia. The Deep and Frequent Phenotyping study which is about to launch, is an example of one such study, which aims to pinpoint the signs of dementia much earlier in the disease development.

Dementia affects over 50 million people worldwide and is the biggest public health crisis facing us in the 21st century. We have stepped up the fights against it with this multi-million pound investment. Whilst the money is crucial, what is also important with a programme of this kind is that what it can achieve is greater than the sum of its parts.
- Professor John Gallacher, Director of Dementias Platform UK.

 

Read more here.

 

 

Similar stories

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

OPDC researchers welcome Parkinson’s UK and the Oxford Branch committee

Researchers from the Oxford Parkinson’s Disease Centre (OPDC) recently hosted Caroline Rassell, Parkinson’s UK Chief Executive; David Dexter, Associate Research Director; Trustee Board members, Gary Shaughnessy (Chair) and Sally Bromley; together with members of the Parkinson’s UK Oxford Branch committee, for a visit to showcase the research being carried out in Oxford.

DPAG launches “Body, Brain, Behavior: Three Views and a Conversation” in Oxford

The Oxford Book Launch 'Body Brain Behavior - The Need For Conversations' brought together three world leading scientist authors, Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch, with Oxford's neuroscience community on Thursday 7 April 2022.